| خلاصه مقاله | Background and Aim: L-carnitine has been reported to be
helpful in the treatment of osteoarthritis due to its prophylactic
role in cartilage degradation. The aim of this study was
to investigate the effect of L-carnitine supplementation on
clinical status in postmenopausal females with knee osteoarthritis
(OA).
Methods: In this clinical trial, 50 obese women with mild to
moderate knee OA were randomly divided into two groups
to receive 750 mg/day L-carnitine (n=25) or placebo (n=25)
for 8 weeks. Clinical symptoms were assessed using the
WOMAC Osteoarthritis Index. Data were analyzed by paired
t-test, independent t-test, and analysis of covariance.
Results: Only 48 patients (23 in the L-carnitine group and
25 in the placebo group) completed the study. Compared
with baseline values, significant reductions of 42% (46.61 to
27.10), 48% (10.86 to 5.61), 48% (3.00 to 1.56) and 39% (32.73
to 19.91) in WOMAC total score and pain, stiffness, and physical
function sub-scores, respectively were observed in the
females supplemented with L-carnitine (P<0.001). Furthermore,
in the placebo group, significant reductions were only
observed in WOMAC pain sub-score (9.85 to 8.11, P=0.023).
The results of ANCOVA showed statistically significant differences
between the two studied groups in WOMAC total
score and sub-scores at the end of the study, adjusted for
baseline values (P<0.05).
Conclusion: Although further studies are needed to confirm
positive effects of L-carnitine on clinical status in knee OA
patients, it seems that L-carnitine may provide a new complementary
approach for patients with osteoarthritis of the
knee. |